Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The Lancet

• Publication date

  2013-07-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(13)60595-4PMID 23727170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteinuria and life expectancy.

  2013cited by this paper
• Evolving importance of kidney disease: from subspecialty to global health burden.

  2013cited by this paper
• Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis

  2013cited by this paper
• Notice

  2012cited by this paper
• Lipid disorders in uremia and dialysis.

  2012cited by this paper
• Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

  2012cited by this paper
• Chronic kidney disease and life expectancy.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

  2012cited by this paper
• Vitamin D therapy in chronic kidney disease and end stage renal disease.

  2012cited by this paper
• Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

  2012cited by this paper
• Age and association of kidney measures with mortality and end-stage renal disease.

  2012cited by this paper
• Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers.

  2012cited by this paper
• Sodium intake, ACE inhibition, and progression to ESRD.

  2012cited by this paper
• Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.

  2012cited by this paper
• The Diagnostic Utility of Cardiac Biomarkers in Dialysis Patients

  2012cited by this paper
• Notice

  2012cited by this paper
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

  2012cited by this paper
• Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease

  2012cited by this paper
• Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease

  2012cited by this paper
• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  2011cited by this paper
• Treatment disparities in acute coronary syndromes, heart failure, and kidney disease.

  2011cited by this paper
• Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.

  2011cited by this paper
• Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials.

  2011cited by this paper
• Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

  2011cited by this paper
• Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study

  2011cited by this paper
• Obesity and chronic kidney disease.

  2011cited by this paper
• Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial

  2011cited by this paper
• Statins, inflammation and kidney disease

  2011cited by this paper
• Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

  2011cited by this paper
• Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study.

  2011cited by this paper
• Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

  2011cited by this paper
• Subclinical atherosclerotic changes related to chronic kidney disease in asymptomatic black and white young adults: the Bogalusa heart study.

  2011cited by this paper
• Sudden cardiac death in hemodialysis patients: an in-depth review.

  2011cited by this paper
• Exercise training for adults with chronic kidney disease.

  2011cited by this paper
• Management of Acute Coronary Syndrome in Patients with Chronic Kidney Disease: If We Don’t Risk Anything, We Risk Even More

  2011cited by this paper
• Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

  2011cited by this paper
• Albuminuria: is it time to screen the general population?

  2011cited by this paper
• Smoking is a risk factor in the progression to kidney failure.

  2011cited by this paper
• CKD treatment: time to alter the focus to albuminuria?

  2011cited by this paper
• The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

  2011cited by this paper
• Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.

  2011cited by this paper
• Health-Adjusted Life Expectancy among Canadian Adults with and without Hypertension

  2011cited by this paper
• The Remission Clinic approach to halt the progression of kidney disease.

  2011cited by this paper
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

  2010cited by this paper
• [Are cardioprotective drugs underused after a myocardial infarction in patients who suffer from chronic kidney disease?].

  2010cited by this paper
• Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R

  2010cited by this paper
• Intensive blood-pressure control in hypertensive chronic kidney disease.

  2010cited by this paper
• Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

  2010cited by this paper
• La pharmacopée de prévention cardiovasculaire est-elle sous-utilisée chez les patients souffrant d’insuffisance rénale chronique après un infarctus du myocarde ?

  2010cited by this paper
• Drug‐eluting stents in patients with end‐stage renal disease: Meta‐analysis and systematic review of the literature

  2010cited by this paper
• Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register

  2010cited by this paper
• Heart Failure, Chronic Kidney Disease, and Biomarkers

  2010cited by this paper
• Albuminuria and the risk of incident stroke and stroke types in older adults

  2010cited by this paper
• Original Contribution Physical Activity and Albuminuria

  2010cited by this paper
• Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

  2010cited by this paper
• Coronary revascularisation in chronic kidney disease. Part II: acute coronary syndromes.

  2010cited by this paper
• Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--.

  2010cited by this paper
• Lowering blood pressure reduces renal events in type 2 diabetes.

  2009cited by this paper
• Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.

  2009cited by this paper
• A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

  2009cited by this paper
• Low protein diets for chronic kidney disease in non diabetic adults.

  2009cited by this paper
• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

  2009cited by this paper
• High protein intake associates with cardiovascular events but not with loss of renal function.

  2009cited by this paper
• The role of medical liability reform in federal health care reform.

  2009cited by this paper
• Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

  2009cited by this paper
• Low protein diets for chronic kidney disease in non diabetic adults.

  2009cited by this paper
• Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients.

  2009cited by this paper
• Cardiac MRI for detection of unrecognized myocardial infarction in patients with end-stage renal disease: comparison with ECG and scintigraphy.

  2009cited by this paper
• Relationship Between Blood Pressure Category and Incidence of Stroke and Myocardial Infarction in an Urban Japanese Population With and Without Chronic Kidney Disease: The Suita Study

  2009cited by this paper
• Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.

  2009cited by this paper
• Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial.

  2009cited by this paper
• Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD)

  2009cited by this paper
• Overview of the Alberta Kidney Disease Network

  2009cited by this paper
• Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis.

  2009cited by this paper
• Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.

  2008cited by this paper
• Endocrine functions of bone in mineral metabolism regulation.

  2008cited by this paper
• Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.

  2008cited by this paper
• Screening for chronic kidney disease: where does Europe go?

  2008cited by this paper
• All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

  2008cited by this paper
• Cardiorenal syndrome.

  2008cited by this paper
• Role of remission clinics in the longitudinal treatment of CKD.

  2008cited by this paper
• Effect of a multifactorial intervention on mortality in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.

  2007cited by this paper
• Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease.

  2007cited by this paper
• Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

  2007cited by this paper
• Chronic Kidney Disease: Effects on the Cardiovascular System

  2007cited by this paper
• Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.

  2007cited by this paper
• Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.

  2007cited by this paper
• Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease.

  2007cited by this paper
• Correction of anemia with epoetin alfa in chronic kidney disease.

  2006cited by this paper
• Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage

  2006cited by this paper
• Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon

  2006cited by this paper
• Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

  2006cited by this paper
• Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study.

  2006cited by this paper
• Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

  2005cited by this paper
• Stiffness of Capacitive and Conduit Arteries: Prognostic Significance for End-Stage Renal Disease Patients

  2005cited by this paper
• Association of physical activity with mortality in the US dialysis population.

  2005cited by this paper

• Predictive value of the triglyceride-glucose index for adverse clinical outcomes in chronic kidney disease

  2026cites this paper
• Multicentre, retrospective observational study on risk factors of major cardiovascular adverse events in patients with chronic kidney disease in Taiwan

  2026cites this paper
• Predicting 1-Year Mortality in Patients with Non-ST Elevation Myocardial Infarction (NSTEMI) Using Survival Models and Aortic Pressure Signals Recorded During Cardiac Catheterization

  2026cites this paper
• The creatinine-to-body weight ratio predicts mortality in critically ill patients with heart failure: a retrospective cohort study of the MIMIC-IV database

  2026cites this paper
• Differential impact of advanced glycation end-products on cardiovascular risk across patient populations measured by skin autofluorescence: a meta-analysis

  2026cites this paper
• Identification of monogenic variants in steroid-resistant and steroid-sensitive nephrotic syndrome.

  2026cites this paper
• Hypertension in Patients With End-Stage Kidney Disease Requiring Dialysis: Bridging the Divide Between Evidence and Practice.

  2026cites this paper
• Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC).

  2026cites this paper
• MARKERS OF SEVERITY IN CHRONIC SYSTEMIC DISEASES: A SYSTEMATIC REVIEW

  2026cites this paper
• Association of Remnant Cholesterol Inflammatory Index with Stroke, Heart Disease and All-Cause Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: A National Cohort Study

  2026cites this paper
• Ten-Year Clinical Outcomes and Cause of Death in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: A Retrospective Mayo Clinic PCI Registry Analysis.

  2026cites this paper
• Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease

  2026cites this paper
• Diastolic dysfunction and the risk of end-stage kidney disease among patients with non-dialysis-dependent chronic kidney disease.

  2026cites this paper
• Serum malondialdehyde-modified low-density lipoprotein level is a risk factor for peripheral artery disease in patients with stage 3 to 5 chronic kidney disease

  2026cites this paper
• Physical Activity and Bidirectional Stage Transitions in Cardiovascular-Kidney-Metabolic Syndrome: A Cohort Study

  2026cites this paper
• Comprehensive Conservative Management as Rescue Therapy After Haemodialysis Failure: Two Case Reports.

  2026influential citation
• Prediction of estimated glomerular filtration rate slope and kidney prognosis of patients with chronic kidney disease.

  2026cites this paper
• Association Between Renal Dysfunction and Cerebral Small Vessel Disease: A Prospective Cohort Study From the UK Biobank

  2026cites this paper
• Arterial stiffening in children with early chronic kidney disease is associated with blood pressure but not decline in kidney function: a longitudinal study from the HOT-KID cohort.

  2026cites this paper
• Unveiling sex-specific cardiometabolic and adiposity risk profiles for precision prevention

  2026cites this paper
• Association of insulin resistance indices with major adverse cardiovascular events in patients with acute myocardial infarction and chronic Kidney disease: a retrospective cohort study

  2026cites this paper
• [Discrepancies in the perception of chronic kidney disease detection and proper management among medical specialties in Spain].

  2026cites this paper
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome

  2026cites this paper
• The calcimimetic etelcalcetide attenuates pressure overload-induced cardiac hypertrophy in rats with and without chronic kidney disease.

  2026cites this paper
• Mediterranean diet with high-phenolic EVOO slows kidney function decline and reduces inflammation in nondialysis CKD: a meta-analysis

  2026cites this paper
• Machine learning-based nomogram predicts heart failure risk in elderly relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy

  2025influential citation
• Mechanism of Rhizoma Chuanxiong for the treatment of diabetic kidney disease based on network pharmacology

  2025cites this paper
• Effect of renal function on dual antiplatelet therapy using cilostazol for stroke prevention: a CSPS.com trial post hoc analysis.

  2025cites this paper
• Role of Transport Proteins for the Renal Handling of L-Arginine and Related Derivatives

  2025cites this paper
• Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010–2019): A Population-Based Study Using a Machine Learning Classification Algorithm

  2025cites this paper
• Menopause and risk of atherosclerotic cardiovascular disease: insights from a women's UK Biobank cohort.

  2025cites this paper
• Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study

  2025cites this paper
• Urinary Sodium and Potassium Excretion and the Risk of Cardiovascular Events in CKD

  2025cites this paper
• InspeCKD – Analyse zur Prävalenz, Diagnose und Therapie der chronischen Nierenerkrankung

  2025cites this paper
• Hepatitis C virus and cardiovascular disease: Current knowledge and unmet needs

  2025cites this paper
• Association of accelerometer-measured physical activity with adverse cardiovascular outcomes in individuals with or without chronic kidney diseases: the UK biobank study

  2025cites this paper
• Protein risk scores enable precise prediction of cardiovascular events in chronic kidney disease patients

  2025cites this paper
• Association between cardiovascular-kidney-metabolic health metrics and long-term cardiovascular risk: Findings from the Chinese Multi-provincial Cohort Study

  2025cites this paper
• Glucose-containing vs. glucose-free dialysate for patients with maintenance hemodialysis: Study protocol for a multicenter randomized controlled study-GLUMO study

  2025cites this paper
• PRevEnting FracturEs in REnal Disease-1 (PREFERRED-1): protocol for a pilot study of a pragmatic, randomised controlled trial of denosumab for the prevention of fragility fractures in haemodialysis

  2025cites this paper
• Gut microbiota implication in diabetic kidney disease: mechanisms and novel therapeutic strategies

  2025cites this paper
• Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis

  2025cites this paper
• Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis.

  2025cites this paper
• The Prognostic Impact of Kidney Dysfunction in Unselected Patients Undergoing Coronary Angiography: In What Subgroups Does Kidney Dysfunction Matter?

  2025cites this paper
• Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease.

  2025cites this paper
• Rapid electrochemical sensing of arsenic-based feed additive using a neodymium orthovanadate-modified electrode: a tool for minimizing arsenic exposure-linked kidney and cardiovascular health risks.

  2025cites this paper
• Stress hyperglycemia ratio and its correlation with long-term prognosis in ACS patients with chronic kidney disease: a retrospective study

  2025cites this paper
• The Life of a Kidney Podocyte

  2025cites this paper
• Phenotypic screening and genetic insights for predicting major vascular-related diseases using retinal imaging

  2025cites this paper
• The prognostic role of hemoglobin, albumin, lymphocyte, and platelets score in peritoneal dialysis

  2025cites this paper
• Nursing Diagnoses and Interventions in the Field of Action for Patients Undergoing Renal Replacement Therapy: A Scoping Review

  2025cites this paper
• Management and treatment of chronic kidney disease in the Danish Lolland-Falster Health Study: focus on renoprotection and cardiovascular disease prevention

  2025cites this paper
• Left atrial energy loss as a novel predictor of mortality and cardiovascular events in chronic kidney disease patients with preserved ejection fraction

  2025cites this paper
• Renal Dysfunction, Coronary Artery Lesion Complexity, and Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome

  2025cites this paper
• Indoxyl sulfate: fuelling cardiovascular inflammation and calcification.

  2025cites this paper
• The Swedish Renal Registry: a nationwide registry for chronic kidney disease of all stages

  2025cites this paper
• Diagnostic value of the urea-to-creatinine ratio for gastrointestinal bleeding source: influence of renal function

  2025cites this paper
• Verification of the T50 Calciprotein Crystallization test: bias estimation and interferences

  2025cites this paper
• Joint association of non-alcoholic fatty liver disease and chronic kidney disease with risk of cardiovascular diseases and all-cause mortality in new-onset diabetes mellitus patients.

  2025cites this paper
• Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs

  2025cites this paper
• Chronic kidney disease and cardiovascular disease risk: exploring the role of socioeconomic position in a large cohort from Northwest Italy.

  2025cites this paper
• Regular Physical Activity is Associated with Slower Age-Related Iohexol Clearance Decline in the General Population Without Diabetes.

  2025cites this paper
• Cost-effectiveness of treatment with finerenone in mild to advanced stage chronic kidney disease patients with type 2 diabetes from a societal perspective

  2025cites this paper
• Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications

  2025cites this paper
• Association of Life's Essential 8 with risk of incident cardiovascular disease and mortality among adults with chronic kidney disease

  2025cites this paper
• A gain-of-function mutation in ATP6V0A4 drives primary distal renal tubular alkalosis with enhanced V-ATPase activity

  2025cites this paper
• Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United States

  2025cites this paper
• A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome.

  2025cites this paper
• Association of intra-individual differences in estimated GFR by creatinine versus cystatin C with incident cardiovascular disease.

  2025cites this paper
• Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis

  2025cites this paper
• Cardiovascular–kidney–metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study

  2025cites this paper
• Renal function trajectories of Japanese adults with diabetic kidney disease on different diet therapies including energy-restricted and low-carbohydrate diets: a retrospective cohort study

  2025cites this paper
• Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.

  2025cites this paper
• Association between the coexistence of chronic kidney disease and sarcopenia with cardiovascular disease and mortality

  2025cites this paper
• Mission and One-Year Experience of a Kidney–Heart Outpatient Service: A Patient-Centered Management Model

  2025cites this paper
• Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation

  2025cites this paper
• Effect of N-Acetylcysteine in Mitochondrial Function, Redox Signaling, and Sirtuin 3 Levels in the Heart During Cardiorenal Syndrome Type 4 Development

  2025cites this paper
• Association of joint exposure to multiple brominated flame retardants with kidney impairment risk among adult population: Evidence from non-pooled samples of NHANES.

  2025cites this paper
• Effects of Prothrombin on Podocytopathy and Proteinuria in Glomerular Disease.

  2025cites this paper
• Relationship between Cumulative Exposure and Time Course of Plasma Aldosterone Concentrations and Chronic Kidney Disease in Hypertensive Patients: A Real-World Cohort Study

  2025cites this paper
• Association between mild renal insufficiency, inflammatory status on initial admission, and 1-year mortality following ST-segment elevation myocardial infarction

  2025influential citation
• Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based study

  2025cites this paper
• Osteoarthritis is a risk factor for renal function injury based on the National Health and Nutrition Examination Survey and Mendelian Randomized study

  2025cites this paper
• Renal hyperfiltration is associated with a reduced incidence of hypertension in individuals younger than 70

  2025cites this paper
• Global trends and disparities in the burden of heart failure caused by chronic kidney disease: an analysis of the global burden of disease study 2021

  2025cites this paper
• Mortality Trends in Patients Undergoing Hemodialysis, 2003–2021: Data from National Health Insurance Service in Korea

  2025cites this paper
• Assessment of aortic and iliac artery calcification using CT-angiography in kidney transplant candidates

  2025cites this paper
• Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration rate

  2025cites this paper
• Deescalation From Ticagrelor to Clopidogrel for Myocardial Infarction With Chronic Kidney Disease

  2025cites this paper
• Developing comprehensive hypertension ontology: Addressing data integration gaps to improve healthcare results

  2025cites this paper
• A cross-sectional and longitudinal cohort study of creatinine-to-cystatin C ratio and cardiovascular disease risk in a middle-aged and elderly population

  2025cites this paper
• Association of renal hyperfiltration with incidence of dyslipidemia: a nationwide retrospective longitudinal cohort study

  2025influential citation
• Evaluation of Serum GPR-120 Levels in Diabetic Patients With and Without Nephropathy: A Comparative Study on Lipid and Renal Parameters

  2025cites this paper
• Life’s Crucial 9 score and chronic kidney disease: insights from NHANES 2005–2018 and the mediating role of systemic inflammation and oxidative stress

  2025cites this paper
• Comparative analysis of plasma BNP and NT-proBNP levels, and NT-proBNP/BNP ratio in patients with chronic kidney disease

  2025cites this paper
• The Impact of Age and Sex on Left Ventricular Function Based on Transthoracic Echocardiograms

  2025cites this paper
• Impact of Nurse-Led Cardiovascular Risk Assessment and Management Program on 1-Year Outcomes in Patients on Hemodialysis Post Percutaneous Coronary Intervention.

  2025cites this paper
• Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update

  2025cites this paper
• Characteristics of Hemodialysis Patients and Renal Transplant Recipients Undergoing Cardiovascular Intervention: Is It Possible to Predict Cardiac Risk?

  2025cites this paper
• Cardiovascular disease risk assessment, exercise training, and management of complications in patients with chronic kidney disease

  2025cites this paper